Literature DB >> 33668713

Organoids Are Limited in Modeling the Colon Adenoma-Carcinoma Sequence.

Yoshihisa Tokumaru1,2, Masanori Oshi1,3, Ankit Patel1, Wanqing Tian4, Li Yan4, Nobuhisa Matsuhashi2, Manabu Futamura2, Kazuhiro Yoshida2, Kazuaki Takabe1,3,5,6,7,8.   

Abstract

The colon adenoma-carcinoma sequence is a multistep genomic-altering process that occurs during colorectal cancer (CRC) carcinogenesis. Organoids are now commonly used to model both non-cancerous and cancerous tissue. This study aims to investigate how well organoids mimic tissues in the adenoma-carcinoma sequence by comparing their transcriptomes. A total of 234 tissue samples (48 adenomas and 186 CRC) and 60 organoid samples (15 adenomas and 45 CRC) were analyzed. We found that cell-proliferation-related gene sets were consistently enriched in both CRC tissues and organoids compared to adenoma tissues and organoids by gene set enrichment analysis (GSEA). None of the known pathways in the colon adenoma-carcinoma sequence were consistently enriched in CRC organoids. There was no enrichment of the tumor microenvironment-related gene sets in CRC organoids. CRC tissues enriched immune-response-related gene sets, whereas CRC organoids did not. The proportions of infiltrating immune cells were different between tissues and organoids, whereas there was no difference between cancer and adenoma organoids. The amounts of cancer stem cells and progenitor cells were not different between CRC and adenoma organoids, whereas a difference was noted between CRC and adenoma tissues. In conclusion, we demonstrated that organoids model only part of the adenoma-carcinoma sequence and should be used with caution after considering their limitations.

Entities:  

Keywords:  CIBERSORT; GSEA; adenoma–carcinoma sequence; colorectal cancer; organoid; tumor microenvironment; xCell

Year:  2021        PMID: 33668713      PMCID: PMC7996178          DOI: 10.3390/cells10030488

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  36 in total

Review 1.  Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery.

Authors:  Fleur Weeber; Salo N Ooft; Krijn K Dijkstra; Emile E Voest
Journal:  Cell Chem Biol       Date:  2017-07-27       Impact factor: 8.116

2.  Evolution of cancer of the colon and rectum.

Authors:  B C Morson
Journal:  Cancer       Date:  1974-09       Impact factor: 6.860

Review 3.  Organogenesis in a dish: modeling development and disease using organoid technologies.

Authors:  Madeline A Lancaster; Juergen A Knoblich
Journal:  Science       Date:  2014-07-17       Impact factor: 47.728

4.  Murine breast cancer mastectomy model that predicts patient outcomes for drug development.

Authors:  Eriko Katsuta; Omar M Rashid; Kazuaki Takabe
Journal:  J Surg Res       Date:  2017-11       Impact factor: 2.192

5.  Prospective derivation of a living organoid biobank of colorectal cancer patients.

Authors:  Marc van de Wetering; Hayley E Francies; Joshua M Francis; Gergana Bounova; Francesco Iorio; Apollo Pronk; Winan van Houdt; Joost van Gorp; Amaro Taylor-Weiner; Lennart Kester; Anne McLaren-Douglas; Joyce Blokker; Sridevi Jaksani; Sina Bartfeld; Richard Volckman; Peter van Sluis; Vivian S W Li; Sara Seepo; Chandra Sekhar Pedamallu; Kristian Cibulskis; Scott L Carter; Aaron McKenna; Michael S Lawrence; Lee Lichtenstein; Chip Stewart; Jan Koster; Rogier Versteeg; Alexander van Oudenaarden; Julio Saez-Rodriguez; Robert G J Vries; Gad Getz; Lodewyk Wessels; Michael R Stratton; Ultan McDermott; Matthew Meyerson; Mathew J Garnett; Hans Clevers
Journal:  Cell       Date:  2015-05-07       Impact factor: 41.582

Review 6.  Organoid technology and applications in cancer research.

Authors:  Hanxiao Xu; Xiaodong Lyu; Ming Yi; Weiheng Zhao; Yongping Song; Kongming Wu
Journal:  J Hematol Oncol       Date:  2018-09-15       Impact factor: 17.388

7.  Determining cell type abundance and expression from bulk tissues with digital cytometry.

Authors:  Aaron M Newman; Chloé B Steen; Chih Long Liu; Andrew J Gentles; Aadel A Chaudhuri; Florian Scherer; Michael S Khodadoust; Mohammad S Esfahani; Bogdan A Luca; David Steiner; Maximilian Diehn; Ash A Alizadeh
Journal:  Nat Biotechnol       Date:  2019-05-06       Impact factor: 54.908

8.  Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes-The University College London Hospital (UCLH) Experience.

Authors:  Nalinie Joharatnam-Hogan; William Wilson; Kai Keen Shiu; Giuseppe Kito Fusai; Brian Davidson; Daniel Hochhauser; John Bridgewater; Khurum Khan
Journal:  Cancers (Basel)       Date:  2020-11-27       Impact factor: 6.639

9.  CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer.

Authors:  Masanori Oshi; Mariko Asaoka; Yoshihisa Tokumaru; Li Yan; Ryusei Matsuyama; Takashi Ishikawa; Itaru Endo; Kazuaki Takabe
Journal:  Int J Mol Sci       Date:  2020-09-22       Impact factor: 5.923

View more
  8 in total

1.  Low RUFY3 expression level is associated with lymph node metastasis in older women with invasive breast cancer.

Authors:  Fernando A Angarita; Masanori Oshi; Akimitsu Yamada; Li Yan; Ryusei Matsuyama; Stephen B Edge; Itaru Endo; Kazuaki Takabe
Journal:  Breast Cancer Res Treat       Date:  2022-01-12       Impact factor: 4.872

2.  Intratumoral lymphatic endothelial cell infiltration reflecting lymphangiogenesis is counterbalanced by immune responses and better cancer biology in the breast cancer tumor microenvironment.

Authors:  Rongrong Wu; Joy Sarkar; Yoshihisa Tokumaru; Yamato Takabe; Masanori Oshi; Mariko Asaoka; Li Yan; Takashi Ishikawa; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

3.  Higher intra-tumoral expression of pro-coagulation genes is a predictor of angiogenesis, epithelial mesenchymal transition and worse patient survival in gastric cancer.

Authors:  Masanori Oshi; Joy Sarkar; Yoshihisa Tokumaru; Li Yan; Takashi Kosaka; Hirotoshi Akiyama; Masayuki Nagahashi; Chikara Kunisaki; Itaru Endo; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

4.  Conflicting roles of EGFR expression by subtypes in breast cancer.

Authors:  Masanori Oshi; Shipra Gandhi; Yoshihisa Tokumaru; Li Yan; Akimitsu Yamada; Ryusei Matsuyama; Takashi Ishikawa; Itaru Endo; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2021-10-15       Impact factor: 5.942

5.  Low expression of miR-195 is associated with cell proliferation, glycolysis and poor survival in estrogen receptor (ER)-positive but not in triple negative breast cancer.

Authors:  Yoshihisa Tokumaru; Masanori Oshi; Ankit Patel; Eriko Katsuta; Li Yan; Fernando A Angarita; Subhamoy Dasgupta; Masayuki Nagahashi; Nobuhisa Matsuhashi; Manabu Futamura; Kazuhiro Yoshida; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

6.  Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment.

Authors:  Shipra Gandhi; Masanori Oshi; Vijayashree Murthy; Elizabeth A Repasky; Kazuaki Takabe
Journal:  Cancers (Basel)       Date:  2021-05-23       Impact factor: 6.575

7.  Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer.

Authors:  Yoshihisa Tokumaru; Masanori Oshi; Michelle R Huyser; Li Yan; Masahiro Fukada; Nobuhisa Matsuhashi; Manabu Futamura; Yukihiro Akao; Kazuhiro Yoshida; Kazuaki Takabe
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

8.  Octogenarians' Breast Cancer Is Associated with an Unfavorable Tumor Immune Microenvironment and Worse Disease-Free Survival.

Authors:  Maiko Okano; Masanori Oshi; Swagoto Mukhopadhyay; Qianya Qi; Li Yan; Itaru Endo; Toru Ohtake; Kazuaki Takabe
Journal:  Cancers (Basel)       Date:  2021-06-11       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.